Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -0.98
- Piotroski Score 5.00
- Grade Outperform
- Symbol (MLAB)
- Company Mesa Laboratories, Inc.
- Price $100.76
- Changes Percentage (2.19%)
- Change $2.17
- Day Low $98.72
- Day High $102.92
- Year High $141.17
Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. Its Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enables to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The company's Calibration Solutions segment designs, manufactures, and markets quality control and calibration products to measure or calibrate temperature, pressure, pH, humidity, and other such parameters used for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory and healthcare environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. Its Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in several therapeutic areas, such as newborn screenings, pharmacogenetics, and oncology. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.
- Last Earnings 10/02/2024
- Ex-Dividend for 5/16 Dividend 11/29/2024
- Dividend Payable 12/16/2024
- Today N/A
- Next Earnings (Estimated) 02/03/2025
- Fiscal Year End N/A
- Average Stock Price Target $120.00
- High Stock Price Target $120.00
- Low Stock Price Target $120.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$47.20
- Trailing P/E Ratio -2.22
- Forward P/E Ratio -2.22
- P/E Growth -2.22
- Net Income $-254,246,000
Income Statement
Quarterly
Annual
Latest News of MLAB
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Conestoga Capital Advisors Sold Mesa Laboratories (MLAB) Due to Inconsistent Performance
Conestoga Capital Advisors' Q2 2024 investor letter discusses the moderation in economic indicators, impacting equity markets. Their Micro-Cap Strategy underperformed due to negative stock selection e...
By Yahoo! Finance | 3 months ago -
What Does Mesa Laboratories, Inc.'s (NASDAQ:MLAB) Share Price Indicate?
Mesa Laboratories, Inc. (NASDAQ:MLAB) has shown a 30% share price increase recently, making it potentially undervalued. With a stable share price and a positive growth outlook, it presents a good buyi...
By Yahoo! Finance | 3 months ago
